A detailed history of Sender CO & Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Sender CO & Partners, Inc. holds 1,272 shares of AMGN stock, worth $401,952. This represents 1.04% of its overall portfolio holdings.

Number of Shares
1,272
Previous 2,155 40.97%
Holding current value
$401,952
Previous $612,000 35.13%
% of portfolio
1.04%
Previous 1.36%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $232,008 - $281,950
-883 Reduced 40.97%
1,272 $397,000
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $579,414 - $699,426
2,155 New
2,155 $612,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sender CO & Partners, Inc. Portfolio

Follow Sender CO & Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sender CO & Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sender CO & Partners, Inc. with notifications on news.